Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exposure to inorganic particles in paediatric sarcoidosis: the PEDIASARC study.
Nathan N, Montagne ME, Macchi O, Rosental PA, Chauveau S, Jeny F, Sesé L, Abou Taam R, Brocvielle M, Brouard J, Catinon M, Chapelon-Abric C, Cohen-Aubart F, Delacourt C, Delestrain C, Deschildre A, Dossier A, Epaud R, Haroche J, Houdouin V, Israel-Biet D, Juvin K, Le Jeune S, Lionnet F, Meinzer U, Mittaine M, Nunes H, Mattioni S, Naccache JM, Odièvre MH, Vincent M, Clement A, Valeyre D, Cavalin C; French Sarcoidosis Group and the Silicosis Research Group. Nathan N, et al. Among authors: odievre mh. Thorax. 2022 Apr;77(4):404-407. doi: 10.1136/thoraxjnl-2021-217870. Epub 2021 Oct 21. Thorax. 2022. PMID: 34675126
Prognosis of patients with sickle cell disease and COVID-19: a French experience.
Arlet JB, de Luna G, Khimoud D, Odièvre MH, de Montalembert M, Joseph L, Chantalat-Auger C, Flamarion E, Bartolucci P, Lionnet F, Monnier S, Guillaumat C, Santin A. Arlet JB, et al. Among authors: odievre mh. Lancet Haematol. 2020 Sep;7(9):e632-e634. doi: 10.1016/S2352-3026(20)30204-0. Epub 2020 Jun 18. Lancet Haematol. 2020. PMID: 32563282 Free PMC article. No abstract available.
Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in France.
Arlet JB, Lionnet F, Khimoud D, Joseph L, de Montalembert M, Morisset S, Garou A, Cannas G, Cougoul P, Guitton C, Holvoet L, Odièvre MH, Cheminet G, Bartolucci P, Santin A, Bernit E, de Luna G; DREPANO COVID-19 Collaborative Group. Arlet JB, et al. Among authors: odievre mh. Am J Hematol. 2022 Mar 1;97(3):E86-E91. doi: 10.1002/ajh.26432. Epub 2021 Dec 18. Am J Hematol. 2022. PMID: 34882837 Free PMC article. No abstract available.
Deficient mitophagy pathways in sickle cell disease.
Martino S, Arlet JB, Odièvre MH, Jullien V, Moras M, Hattab C, Lefebvre T, Gouya L, Ostuni MA, Lefevre SD, Le Van Kim C. Martino S, et al. Among authors: odievre mh. Br J Haematol. 2021 Jun;193(5):988-993. doi: 10.1111/bjh.17416. Epub 2021 Mar 22. Br J Haematol. 2021. PMID: 33754349 Clinical Trial.
Blood exchange transfusion with dexamethasone and Tocilizumab for management of hospitalized patients with sickle cell disease and severe COVID-19: Preliminary evaluation of a novel algorithm.
De Luna G, Habibi A, Odièvre MH, Guillet H, Guiraud V, Cougoul P, Carpentier B, Loko G, Guichard I, Ourghanlian C, Pawlotsky JM, Mahevas M, Limal N, Michel M, Mekontso-Dessap A, Arlet JB, Bartolucci P. De Luna G, et al. Among authors: odievre mh. Am J Hematol. 2022 Jul;97(7):E260-E264. doi: 10.1002/ajh.26563. Epub 2022 Apr 15. Am J Hematol. 2022. PMID: 35385170 Free PMC article. No abstract available.
46 results